SARS-CoV-2 spike promotes inflammation and apoptosis through autophagy by ROS-suppressed PI3K/AKT/mTOR signaling.
SARS-CoV-2 spike promotes inflammation and apoptosis through autophagy by ROS-suppressed PI3K/AKT/mTOR signaling.
复制标题
DOI:
10.1016/j.bbadis.2021.166260
复制
发表时间:
2021-12-01
期刊:
影响因子:
--
通讯作者:
Zhang Q
中科院分区:
文献类型:
--
作者:
Li F;Li J;Wang PH;Yang N;Huang J;Ou J;Xu T;Zhao X;Liu T;Huang X;Wang Q;Li M;Yang L;Lin Y;Cai Y;Chen H;Zhang Q
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection-induced inflammatory responses are largely responsible for the death of novel coronavirus disease 2019 (COVID-19) patients. However, the mechanism by which SARS-CoV-2 triggers inflammatory responses remains unclear. Here, we aimed to explore the regulatory role of SARS-CoV-2 spike protein in infected cells and attempted to elucidate the molecular mechanism of SARS-CoV-2-induced inflammation. SARS-CoV-2 spike pseudovirions (SCV-2-S) were generated using the spike-expressing virus packaging system. Western blot, mCherry-GFP-LC3 labeling, immunofluorescence, and RNA-seq were performed to examine the regulatory mechanism of SCV-2-S in autophagic response. The effects of SCV-2-S on apoptosis were evaluated by terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL), Western blot, and flow cytometry analysis. Enzyme-linked immunosorbent assay (ELISA) was carried out to examine the mechanism of SCV-2-S in inflammatory responses. Angiotensin-converting enzyme 2 (ACE2)-mediated SCV-2-S infection induced autophagy and apoptosis in human bronchial epithelial and microvascular endothelial cells. Mechanistically, SCV-2-S inhibited the PI3K/AKT/mTOR pathway by upregulating intracellular reactive oxygen species (ROS) levels, thus promoting the autophagic response. Ultimately, SCV-2-S-induced autophagy triggered inflammatory responses and apoptosis in infected cells. These findings not only improve our understanding of the mechanism underlying SARS-CoV-2 infection-induced pathogenic inflammation but also have important implications for developing anti-inflammatory therapies, such as ROS and autophagy inhibitors, for COVID-19 patients.
登录
查看更多内容
影响因子:
9
作者:
Channappanavar R;Perlman S
通讯作者:
Perlman S
影响因子:
13.3
作者:
Hou, Lei;Wei, Li;Liu, Jue
通讯作者:
Liu, Jue
影响因子:
9
作者:
Deng, Huiming;Huang, Ling;Xu, Ronghua
通讯作者:
Xu, Ronghua
影响因子:
11.1
作者:
High, Monica;Cho, Hye-Youn;Kleeberger, Steven R.
通讯作者:
Kleeberger, Steven R.
影响因子:
5.3
作者:
Dong X;Levine B
通讯作者:
Levine B